Cydar Medical, a developer of cloud-based artificial intelligence solutions for endovascular surgery, announced an expanded relea ...

Concept Medical Inc. announced preliminary 3-year follow-up data from the SIRONA randomized trial comparing the company’s M ...

Hjarta Care announced that the FDA has granted de novo authorization for the EVAR XplantR, which is a purpose-built, ...

Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percuta ...

Reva Medical, LLC announced primary endpoint results from the pivotal MOTIV BTK randomized clinical trial evaluating the safety a ...

Angiolutions announced the appointment of four internationally recognized vascular and endovascular specialists to its ...

Recent findings from a substudy of DETOUR2 demonstrated that percutaneous transmural arterial bypass (PTAB) may offer an ...

Vena Medical, a Kitchener, Canada—based developer of direct intravascular imaging systems, announced completion of the firs ...

Gore & Associates announced new 12-month findings from the global GORE VIABAHN FORTEGRA Venous Stent IVC trial, which evaluat ...

Boston Scientific announced an analysis of 989 patients with hepatocellular carcinoma (HCC) from the PROACTIF prospective ...

Efemoral Medical announced long-term results of the first 40 patients treated in the EFEMORAL I first-in-human (FIH) clinical ...

InVera Medical announced 12-month results from its pilot clinical study of the InVera infusion device for the treatment of ...